Drug Shortage Report for SODIUM CHLORIDE INJECTION, USP
Report ID | 159570 |
Drug Identification Number | 02139510 |
Brand name | SODIUM CHLORIDE INJECTION, USP |
Common or Proper name | Sodium Chloride Injection, USP |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | SODIUM CHLORIDE |
Strength(s) | 234MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 200mL |
ATC code | B05XA |
ATC description | I.V. SOLUTION ADDITIVES |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2022-05-01 |
Actual start date | 2022-05-01 |
Estimated end date | 2022-05-19 |
Actual end date | 2022-05-19 |
Shortage status | Resolved |
Updated date | 2022-05-24 |
Company comments | Fresenius Kabi Canada regrets to advise that due to shipping delays, we will be experiencing supply interruptions. Once available, Sodium Chloride Injection, USP 4 mEq/mL Maxivial® 200 mL will be placed on allocation. Contract customers will be allocated 100% of historical monthly volumes. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2022-05-24 | French | Compare |
v6 | 2022-05-24 | English | Compare |
v5 | 2022-05-15 | French | Compare |
v4 | 2022-05-15 | English | Compare |
v3 | 2022-05-02 | English | Compare |
v2 | 2022-04-28 | French | Compare |
v1 | 2022-04-28 | English | Compare |
Showing 1 to 7 of 7